Cure4Cancer initiative proposes solutions for unlocking $80B oncology R&D investment and reducing global cancer disparities

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Cure4Cancer and the Bloomberg New Economy Cancer Coalition published its latest study in Cancer Discovery on the global access and participation in oncology clinical trials, a first of its kind analysis through a multi-stakeholder collaboration. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

The field of surgical oncology has undergone transformative advancements over the last decade. From refining minimally invasive techniques to leveraging immunotherapy and viral oncolytics, our collective goal remains the same: improving patient outcomes while reducing treatment burden. At City of Hope, we have prioritized accelerating the translation of laboratory discoveries into clinical applications, and nowhere is this more evident than in our work with oncolytic viruses, remote surgery, and the integration of AI in surgical decision-making.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login